miércoles, 20 de abril de 2016

Melphalan Hydrochloride - National Cancer Institute

Melphalan Hydrochloride - National Cancer Institute

National Cancer Institute

Melphalan Hydrochloride

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 (MEL-fuh-lan HY-droh-KLOR-ide)
This page contains brief information about melphalan hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s)
FDA Approved

Use in Cancer

Melphalan hydrochloride is approved to treat:
Melphalan hydrochloride is also being studied in the treatment of other types ofcancer.
Melphalan is also available in a tablet form. For more information, see the Drug Information Summary for Melphalan.

More About Melphalan Hydrochloride

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Melphalan Hydrochloride - A lay language summary of important information about this drug that may include the following:
  • warnings about this drug,
  • what this drug is used for and how it is used,
  • what you should tell your doctor before using this drug,
  • what you should know about this drug before using it,
  • other drugs that may interact with this drug, and
  • possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials Accepting Patients

Find Clinical Trials for Melphalan Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.
  • Posted: March 28, 2016
  • Updated: March 28, 2016

No hay comentarios:

Publicar un comentario